The Valley Desk

ArticleClinical and experimental immunologyPublished

Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Clinical and experimental immunology
Published
Subject terms
Humans; Arthritis, Rheumatoid; Tumor Necrosis Factor-alpha; NF-kappa B; Toll-Like Receptor 9; HEK293 Cells; Antibodies, Monoclonal, Humanized; Etanercept; Rheumatoid arthritis; NF-κB; TLR9; Tocilizumab
PubMed ID
37279559
Added to directory
Source checked

Report a correction or request removal